CIBC Private Wealth Group
IMRX icon

CIBC Private Wealth Group’s Immuneering IMRX Stock Holding History

CIBC Private Wealth Group’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$188K Sell
28,500
-21,551
-43% -$138K ﹤0.01% 1222
2025
Q3 		$350K Buy
50,051
+35,051
+234% +$182K ﹤0.01% 970
2025
Q2 		$50.5K Buy
15,000
+5,000
+50% +$8.57K ﹤0.01% 1657
2025
Q1 		$12.5K Hold
10,000
– – ﹤0.01% 2164
2024
Q4 		$20K Hold
10,000
– – ﹤0.01% 2062
2024
Q3 		$24.9K Buy
+10,000
New +$14.5K ﹤0.01% 2063

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC Private Wealth Group's IMRX Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its Immuneering (IMRX) stake by 43% in Q4 2025, selling an estimated $138K and leaving 28,500 shares worth $188K. The position accounts for ﹤0.01% of the portfolio, ranked #1222.

CIBC Private Wealth Group first reported a position in IMRX in Q3 2024 and has held it in 6 quarters since. The position peaked at $350K in Q3 2025. 86 funds tracked by Wall St. Rank hold IMRX as of Q4 2025.

  • CIBC Private Wealth Group held 28,500 shares of Immuneering worth $188K as of Q4 2025.
  • CIBC Private Wealth Group sold 21,551 Immuneering shares in Q4 2025, an estimated $138K.
  • Immuneering made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1222 holding.
  • CIBC Private Wealth Group first reported a position in Immuneering in Q3 2024 and has held it in 6 quarters since.
  • CIBC Private Wealth Group's Immuneering position peaked at $350K in Q3 2025.
  • 86 funds tracked by Wall St. Rank held Immuneering as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.